● Investor
Abingworth
Abingworth is a London-headquartered life sciences investment firm founded in 1973 that backs seed-to-development-stage pharmaceutical and biotechnology companies across the US, Europe, and Asia-Pacific; it was acquired by The Carlyle Group in 2022.
Venture CapitalUnited KingdomSeries A → Series A
Portfolio
1
companies tracked
Rounds · 12mo
1
participated in
Est. deployed · 12moEstimated by summing amounts of tracked rounds. Actual check sizes vary and often aren't disclosed.
$78M
sum of tracked rounds
Top stage
Series A
by round count
Recent activity
Rounds LatestRounds has tracked from this investor.
Where they invest
By stage · rounds, 12mo
Series A1
Frequent co-investors
No repeat co-investors yet.